Lorriana Leard, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Lorriana Leard, MD

Associate Professor of Clinical Medicine
Vice Chief of Clinical Activities, Pulmonary, Critical Care, Allergy & Sleep Medicine
Associate Director, Pulmonary & Critical Care Fellowship Program

Phone: 415-885-3882

View on UCSF Profiles

Research Summary

Dr. Lorri Leard received her undergraduate degree from Stanford University and her M.D. from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she came to the University of California San Francisco for her Pulmonary and Critical Care Fellowship. She completed an additional subspecialty fellowship in Lung Transplantation at the University of California San Francisco and joined the faculty in 2006. She pursued further training in medical education in the UCSF Teaching Scholars program and was selected to join the Academy of Medical Educators in 2011.

Her major academic interests include Lung Transplantation, Interventional Bronchoscopy, and Lung Cancer. She cares for patients on the Lung Transplant and Pulmonary Consult services at UCSF Moffitt-Long Hospital, and sees patients at the Mt. Zion Comprehensive Cancer Center. She also co-directs the UCSF Lung Cancer Screening Program.

Dr. Leard represents UCSF to several national and international organizations including chairing an item writing committee for the National Board of Medical Educators, serving on the Program Committee for the International Society of Heart and Lung Transplantation, and as a member of the Lung Cancer Screening committee for the National Comprehensive Cancer Network.

Selected Publications

  1. Prolonged Barium-Impaction Ileus in Two Lung Transplant Recipients With Systemic Sclerosis: Case Report. Transplant Proc. 2015 Dec; 47(10):2965-7.
    View on PubMed
  2. Lung transplantation for hypersensitivity pneumonitis. Chest. 2015 Jun 1; 147(6):1558-65.
    View on PubMed
  3. Clinical outcomes of lung transplant recipients with telomerase mutations. J Heart Lung Transplant. 2015 May 11.
    View on PubMed
  4. Lung cancer screening, version 1.2015. J Natl Compr Canc Netw. 2015 Jan; 13(1):23-34.
    View on PubMed
  5. The feasibility of lung transplantation in HIV-seropositive patients. Ann Am Thorac Soc. 2014 Jul; 11(6):882-9.
    View on PubMed
  6. Development and validation of a lung transplant-specific disability questionnaire. Thorax. 2014 May; 69(5):437-42.
    View on PubMed
  7. A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions. Am J Transplant. 2013 Apr; 13(4):839-50.
    View on PubMed
  8. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Transpl Infect Dis. 2013 Apr; 15(2):E70-4.
    View on PubMed
  9. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection. Clin Transplant. 2013 Jan-Feb; 27(1):E64-71.
    View on PubMed
  10. Rapidly progressive pulmonary venoocclusive disease in young women taking oral contraceptives. J Heart Lung Transplant. 2012 Sep; 31(9):1031-6.
    View on PubMed
  11. Lung cancer screening. J Natl Compr Canc Netw. 2012 Feb; 10(2):240-65.
    View on PubMed
  12. Use of sublingual tacrolimus in lung transplant recipients. J Heart Lung Transplant. 2012 Feb; 31(2):127-32.
    View on PubMed
  13. An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients. Transpl Int. 2012 Feb; 25(2):172-8.
    View on PubMed
  14. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant. 2011 Oct; 11(10):2197-204.
    View on PubMed
  15. Management of recurrent airway strictures in lung transplant recipients using AERO covered stents. J Vasc Interv Radiol. 2010 Dec; 21(12):1900-4.
    View on PubMed
  16. Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients. J Heart Lung Transplant. 2010 Sep; 29(9):1009-13.
    View on PubMed
  17. Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosis. Respir Med. 2010 Mar; 104(3):426-33.
    View on PubMed
  18. Lung transplantation in patients with connective tissue disorders and esophageal dysmotility. Dis Esophagus. 2008; 21(7):650-5.
    View on PubMed
  19. Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab. J Heart Lung Transplant. 2007 Dec; 26(12):1340-4.
    View on PubMed
  20. Antireflux surgery for patients with end-stage lung disease before and after lung transplantation. Surg Endosc. 2008 Feb; 22(2):495-500.
    View on PubMed

Go to UCSF Profiles, powered by CTSI